Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Optimal timing for salvage surgery after definitive radiotherapy in hypopharyngeal cancer.

Chun SJ, Keam B, Heo DS, Kim KH, Sung MW, Chung EJ, Kim JH, Jung KC, Kim JH, Wu HG.

Radiat Oncol J. 2018 Sep;36(3):192-199. doi: 10.3857/roj.2018.00311. Epub 2018 Sep 30.

2.

Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.

Zelefsky MJ, Kraus DH, Pfister DG, Raben A, Shah JP, Strong EW, Spiro RH, Bosl GJ, Harrison LB.

Head Neck. 1996 Sep-Oct;18(5):405-11.

PMID:
8864731
3.

Salvage surgery for recurrence of laryngeal and hypopharyngeal squamous cell carcinoma: A retrospective study from 2005 to 2013.

Pujo K, Philouze P, Scalabre A, Céruse P, Poupart M, Buiret G.

Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Apr;135(2):111-117. doi: 10.1016/j.anorl.2017.11.001. Epub 2017 Dec 2.

4.
5.
6.

Salvage of recurrent hypopharyngeal carcinoma after primary curative treatment.

Yasumatsu R, Nakashima T, Toh S, Taura M, Komune S.

Acta Otolaryngol. 2013 Oct;133(10):1110-6. doi: 10.3109/00016489.2013.815365. Epub 2013 Aug 7.

PMID:
23919670
7.

Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review.

Putten L, Bree R, Doornaert PA, Buter J, Eerenstein SE, Rietveld DH, Kuik DJ, Leemans CR.

Acta Otorhinolaryngol Ital. 2015 Jun;35(3):162-72. Review.

8.

[Clinical characteristics and treatment strategies for early-stage primary gastric diffuse large B-cell lymphoma].

Qin Y, Liu P, Yang JL, Jin J, He XH, Wang WH, Fang H, Zhou SY, Zhou LQ, Song YW, Shi YK.

Zhonghua Yi Xue Za Zhi. 2018 Jun 26;98(24):1945-1950. doi: 10.3760/cma.j.issn.0376-2491.2018.24.011. Chinese.

PMID:
29996288
9.

[Clinical analysis of posterior hypopharyngeal wall squamous cell carcinoma: a report of 36 cases].

Wang JH, Qi YF, Tang PZ, Wen SX, Zhang ZM, Qin DX.

Ai Zheng. 2005 Sep;24(9):1106-10. Chinese.

PMID:
16159434
10.

Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.

Jeene PM, Versteijne E, van Berge Henegouwen MI, Bergmann JJ, Geijsen ED, Muller K, van Laarhoven HW, Hulshof MC.

Dis Esophagus. 2017 Feb 1;30(2):1-5. doi: 10.1111/dote.12539.

PMID:
27766725
11.

Salvage surgery after induction chemotherapy with paclitaxel/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas.

Relic A, Scheich M, Stapf J, Voelter C, Hoppe F, Hagen R, Pfreundner L.

Eur Arch Otorhinolaryngol. 2009 Nov;266(11):1799-805. doi: 10.1007/s00405-009-0946-3. Epub 2009 Mar 14.

PMID:
19288123
12.

Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.

Chua DT, Wei WI, Sham JS, Cheng AC, Au G.

Head Neck. 2003 Jul;25(7):585-94.

PMID:
12808662
13.

Clinical Outcomes of Definitive and Postoperative Radiotherapy for Stage I-IVB Hypopharyngeal Cancer.

Shirai K, Saitoh JI, Musha A, Abe T, Kobayashi D, Takakusagi Y, Takaysu Y, Shino M, Toyoda M, Takahashi K, Chikamatsu K, Ohno T, Nakano T.

Anticancer Res. 2016 Dec;36(12):6571-6578.

PMID:
27919985
14.

[The results and toxicity of organ preservation treatment for locoregionally advanced laryngeal and hypopharyngeal cancer].

Kiprian D, Kawecki A, Jarząbski A, Michalski W, Pawłowska-Sendułka B.

Otolaryngol Pol. 2011 Sep-Oct;65(5):363-8. doi: 10.1016/S0030-6657(11)70727-2. Polish.

PMID:
22078287
15.

Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.

Lee NY, O'Meara W, Chan K, Della-Bianca C, Mechalakos JG, Zhung J, Wolden SL, Narayana A, Kraus D, Shah JP, Pfister DG.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):459-68. Epub 2007 May 9.

PMID:
17493769
16.

Chemoradiation therapy with or without salvage surgery for early squamous cell carcinoma of the hypopharynx.

Nakamura K, Shioyama Y, Sasaki T, Ohga S, Saku M, Urashima Y, Yoshitake T, Nakashima T, Kuratomi Y, Komune S, Terashima H, Honda H.

Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):680-3.

PMID:
15936545
17.

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.

Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21.

PMID:
16168834
18.

EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer.

Hattori S, Muto M, Ohtsu A, Boku N, Manabe T, Doi T, Ishikura S, Yoshida S.

Gastrointest Endosc. 2003 Jul;58(1):65-70.

PMID:
12838223
19.

Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.

Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA.

Laryngoscope. 2001 Jun;111(6):1079-87.

PMID:
11404625
20.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206

Supplemental Content

Support Center